Skip to main content
TipRanks
Go Ultimate75% OFF

International Stem Cell (ISCO) Stock Statistics & Valuation Metrics

45 Followers

Total Valuation

International Stem Cell has a market cap or net worth of $1.27M. The enterprise value is $3.95T.

Market Cap
$1.27M
Enterprise Value
$3.95T

Share Statistics

International Stem Cell has 8,004,389 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
8,004,389
Owned by Insiders
0.06%
Owned by Institutions
<0.01%

Financial Efficiency

International Stem Cell’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -6.72%.

Return on Equity (ROE)
0.10
Return on Assets (ROA)
-0.09
Return on Invested Capital (ROIC)
-6.72%
Return on Capital Employed (ROCE)
-1.11
Revenue Per Employee
275.76K
Profits Per Employee
-12.67K
Employee Count
33
Asset Turnover
1.89
Inventory Turnover
2.66

Valuation Ratios

The current PE Ratio of International Stem Cell is -2.55. International Stem Cell’s PEG ratio is 0.01.

PE Ratio
-2.55
PS Ratio
0.13
PB Ratio
17.79
Price to FCF
3.85
Price to Operating Cash Flow
3.47
PEG Ratio
0.01

Income Statement

In the last 12 months, International Stem Cell had revenue of 9.10M and earned -418.00K in profits. Earnings per share was -0.05.

Revenue
9.10M
Gross Profit
5.07M
Operating Income
-267.00K
Pretax Income
-418.00K
Net Income
-418.00K
EBITDA
-48.00K
Earnings Per Share (EPS)
-0.05

Cash Flow

In the last 12 months, operating cash flow was 369.00K and capital expenditures -36,000, giving a free cash flow of 333.00K billion.

Operating Cash Flow
369.00K
Free Cash Flow
333.00K
Free Cash Flow per Share
0.04

Dividends & Yields

International Stem Cell pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
26.00%
Earnings Yield
-45.44%

Stock Price Statistics

Beta
-0.96
52-Week Price Change
16.55%
50-Day Moving Average
0.26
200-Day Moving Average
0.22
Relative Strength Index (RSI)
39.71
Average Volume (3m)
38.22K

Financial Position

International Stem Cell as a current ratio of 0.74, with Debt / Equity ratio of -91.95%

Current Ratio
0.74
Quick Ratio
0.41
Debt to Market Cap
2.98
Net Debt to EBITDA
-57.08
Interest Coverage Ratio
-1.77

Taxes

In the past 12 months, International Stem Cell has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

International Stem Cell EV to EBITDA ratio is -22.51, with an EV/FCF ratio of 10.95.

EV to Sales
0.38
EV to EBITDA
-22.51
EV to Free Cash Flow
10.95
EV to Operating Cash Flow
9.88

Balance Sheet

International Stem Cell has $1.09M in cash and marketable securities with $3.46M in debt, giving a net cash position of -$2.37M billion.

Cash & Marketable Securities
$1.09M
Total Debt
$3.46M
Net Cash
-$2.37M
Net Cash Per Share
-$0.30
Tangible Book Value Per Share
-$0.06

Margins

Gross margin is 54.85%, with operating margin of -3.50%, and net profit margin of -6.12%.

Gross Margin
54.85%
Operating Margin
-3.50%
Pretax Margin
-6.12%
Net Profit Margin
-6.12%
EBITDA Margin
-1.70%
EBIT Margin
-3.50%

Analyst Forecast

The average price target for International Stem Cell is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
3.40%
EPS Growth Forecast
-101.06%

Scores

Smart Score
―
AI Score
49